The Latin American IC device market has recovered from the COVID-19 pandemic and is reverting to prepandemic growth trends. Steady uptake of several technologies has supported the IC device space…
With the impact of, and recovery from, the COVID-19 pandemic coming to an end, the European IC device market will shortly witness a return to prepandemic growth trends. Shifting preference toward…
The global deep venous disease treatment device market will experience strong growth due to the increasing uptake of innovative devices, such as powered thrombectomy devices and venous stents,…
The European EP mapping and ablation device market will experience moderate growth through 2032 due to increasing ablation procedure volumes, technological advancements, and the uptake of premium-…
The Japanese EP mapping and ablation device market has recovered largely from the COVID-19 pandemic and will resume moderate growth over the remainder of the forecast period, supported by…
The Asia Pacific dialysis access treatment device market will continue to experience modest growth through 2032 after recovering from the impact of COVID-19. The market will be primarily driven by…
The Japanese IC device market is driven by an expanding CAD patient pool, the growing prevalence of complex lesions, improving access to treatment, the emerging preference for minimally invasive…
Although COVID-19 has negatively impacted the Latin American transcatheter embolization and occlusion device market, the impact of COVID-19 has been limited. The market will expand at a modest rate…
Although the global COVID-19 pandemic negatively impacted the Asia Pacific structural heart closure device market in 2020, strong prepandemic growth trends in the PFO and LAA segments helped to…
Although the global COVID-19 pandemic negatively impacted the Asia Pacific EP mapping and ablation device market in 2020, the market has shown strong recovery and will resume prepandemic growth…
The Latin American EP mapping and ablation device market will experience strong growth as a result of favorable demographic trends and the introduction of product innovations. However, the COVID-19…
The US market for cardiac rhythm management devices will grow through 2032, with trends varying by device segment. The COVID-19 global pandemic had a negative impact on some CRM procedure volumes…
The Asia Pacific heart valve device market will continue to experience robust growth after recovering from the impact of COVID-19. The market will be primarily driven by rapid adoption of THV…
The European market for aortic repair devices is expected to expand modestly over the forecast period. Market growth will be supported by the launch and increasing adoption of new devices that…
The Latin American heart valve device market will be driven by expanding patient pool and improving access to treatment in the Latin American countries. The strong growth through 2031 will be…